Myasthenic crisis

被引：82

作者：

Chaudhuri, A. ^{[1
]}

Behan, P. O. ^{[2
]}

机构：

[1] Univ Glasgow, Essex Ctr Neurol Sci, Glasgow G12 8QQ, Lanark, Scotland

[2] Univ Glasgow, Div Clin Neurosci, Glasgow G12 8QQ, Lanark, Scotland

来源：

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | 2009年 / 102卷 / 02期

关键词：

INTRAVENOUS IMMUNOGLOBULIN; CLINICAL-FEATURES; PLASMA-EXCHANGE; GRAVIS; MUSK; THYMECTOMY; TRIAL; COMPLICATIONS; EXACERBATION; ANTIBODIES;

D O I：

10.1093/qjmed/hcn152

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Myasthenic crisis is a life-threatening medical emergency requiring early diagnosis and respiratory assistance. It can affect between one-fifth and one-third of all patients with generalized autoimmune myasthenia gravis. Myasthenic crisis is to be distinguished from other causes of acute neuromuscular paralysis which in most cases, can be achieved clinically. High dose corticosteroids in combination with plasma exchange or immunoglobulin are the cornerstone of treatment for this fully reversible cause of neuromuscular paralysis.

引用

页码：97 / 107

页数：11

共 40 条

[1] Noninvasive ventilation in acute neuromuscular respiratory failure due to myasthenic crisis: case report and review of literature [J].

Agarwal, R ;

Reddy, C ;

Gupta, D .

EMERGENCY MEDICINE JOURNAL, 2006, 23 (01) :E6-U128

[2] Clinical predictors of steroid-induced exacerbation in myasthenia gravis [J].

Bae, Jong Seok ;

Go, Seok Min ;

Kim, Byoung Joon .

JOURNAL OF CLINICAL NEUROSCIENCE, 2006, 13 (10) :1006-1010

[3] Therapy of myasthenic crisis [J].

Berrouschot, J ;

Baumann, I ;

Kalischewski, P ;

Sterker, M ;

Schneider, D .

CRITICAL CARE MEDICINE, 1997, 25 (07) :1228-1235

[4] Coronary vasospasm secondary to hypercholinergic crisis: An iatrogenic cause of acute myocardial infarction in myasthenia gravis [J].

Comerci, G ;

Buffon, A ;

Biondi-Zoccai, GGL ;

Ramazzotti, V ;

Romagnoli, E ;

Savino, M ;

Rebuzzi, AG ;

Biasucci, LM ;

Loperfido, F ;

Crea, F .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 103 (03) :335-337

[5]

Deem S, 2006, RESP CARE, V51, P1042

[6] Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis [J].

Deymeer, F. ;

Gungor-Tuncer, O. ;

Yilmaz, V. ;

Parman, Y. ;

Serdaroglu, P. ;

Ozdemir, C. ;

Vincent, A. ;

Saruhan-Direskeneli, G. .

NEUROLOGY, 2007, 68 (08) :609-611

[7] Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome [J].

Diaz-Manera, Jordi ;

Rojas-Garcia, Ricard ;

Gallardo, Eduard ;

Juarez, Candido ;

Martinez-Domeno, Alejandro ;

Martinez-Ramirez, Sergi ;

Dalmau, Josep ;

Blesa, Rafael ;

Illa, Isabel .

NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (07) :405-410

[8] MRI and clinical studies of facial and bulbar muscle involvement in MUSK antibody-associated myasthenia gravis [J].

Farrugia, Maria Elena ;

Robson, Matthew D. ;

Clover, Linda ;

Anslow, Phil ;

Newsom-Davis, John ;

Kennett, Robin ;

Hilton-Jones, David ;

Matthews, Paul M. ;

Vincent, Angela .

BRAIN, 2006, 129 :1481-1492

[9] Effects of 8-week, interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis [J].

Fregonezi, GAD ;

Resqueti, VR ;

Güell, R ;

Pradas, J ;

Casan, P .

CHEST, 2005, 128 (03) :1524-1530

[10] Treatment of Myasthenia Gravis exacerbation with intravenous immunoglobulin - A randomized double-blind clinical trial [J].

Gajdos, P ;

Tranchant, C ;

Clair, B ;

Bolgert, F ;

Eymard, B ;

Stojkovic, T ;

Attarian, S ;

Chevret, S .

ARCHIVES OF NEUROLOGY, 2005, 62 (11) :1689-1693

← 1 2 3 4 →